Clinical trial Recruiting at 6 sites Interventional Ages 21 and up

Hypoglossal nerve stimulation for adults with obstructive sleep apnea

Official title: Bilateral Hypoglossal Nerve Stimulation With the XII Medical HGNS System for the Treatment of Adult Obstructive Sleep Apnea Pilot Study

Run by XII Medical · NCT07049744 · Data updated 2026-11-12

This study will test an implanted hypoglossal nerve stimulator to see if it reduces sleep apnea events and improves sleep for adults with moderate to severe OSA who cannot tolerate CPAP.

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment30 (estimated)
SponsorXII Medical
Industry-sponsored
Locations6 sites (Canberra, Australian Capital Territory and 5 other locations)
StatusRecruiting
StartedJune 24, 2025
Main results expectedDecember 2026
Study endsJune 2029
Registry record updatedJuly 30, 2026
Trial IDNCT07049744 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with moderate-to-severe OSA (AHI 15–50), BMI ≤32 kg/m2, central+mixed apnea index ≤25%, who have not tolerated, failed, or refused PAP are the intended candidates.

Probably not a fit

Patients with significant positional OSA, complete concentric soft palate collapse on DISE, central sleep apnea, hypoglossal nerve weakness, major airway anatomic abnormalities, high surgical risk, or those taking GLP-1 medications are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants will be implanted with the XII Medical hypoglossal nerve stimulation system which delivers targeted electrical pulses to the hypoglossal nerve during sleep. After device implantation, participants will use the device at home overnight and attend scheduled sleep studies to record breathing events and sleep quality. The trial enrolls adults with moderate-to-severe OSA (AHI 15–50) with BMI ≤32 and limited central/mixed apneas, and excludes those with complete concentric palatal collapse, significant positional OSA, or other contraindications to surgery. Safety and device performance will be monitored through follow-up visits and objective sleep testing over the study period.

Why it matters

Potential benefit: If successful, the device could reduce apneas and improve nighttime breathing and daytime sleepiness for patients who cannot use CPAP.

How similar studies have gone: Other hypoglossal nerve stimulation systems have shown benefit in carefully selected patients with moderate-to-severe OSA, though outcomes vary by device and patient selection.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Body Mass Index (BMI) ≤ 32 kg/m2
* AHI of 15-50 events/hour
* Central + mixed apnea index ≤ 25%
* Participants who have either not tolerated, have failed or refused positive airway pressure (PAP)

Exclusion Criteria:

* Pregnancy or breast-feeding.
* Significant upper airway anatomic abnormalities
* Hypoglossal nerve weakness
* Central sleep apnoea condition
* Significant positionally-dependent OSA.
* Complete concentric patterns of soft palate collapse on DISE
* Inadequately treated non-OSA sleep disorder(s).
* Significant co-morbidities or prior surgeries that contra-indicate a surgical procedure or general anesthesia
* Taking medications that in the opinion of the investigator may alter consciousness, the pattern of respiration, or sleep architecture
* Participants on a GLP-1

Where it's running

  • Canberra ENT
    Canberra, Australian Capital Territory, Australia
    Recruiting
  • Woolcock Institute Of Medical Research
    Sydney, New South Wales, Australia
    Recruiting
  • Westmead Hospital / Chris O'Brien Lifehouse
    Sydney, New South Wales, Australia
    Recruiting
  • The Wollongong Hospital
    Wollongong, New South Wales, Australia
    Recruiting
  • Princess Alexandra Hospital
    Brisbane, Queensland, Australia
    Recruiting
  • Perth Head & Neck Surgery
    Perth, Western Australia, Australia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.